关于在治疗耐药性下尽量减少瘤生长
Matthias M Fischer1, Nils Blüthgen1
1Institute for Theoretical Biology, Charité and Humboldt Universität zu Berlin, 10115 Berlin, Germany.
Journal of theoretical biology
|December 22, 2023
概括
简单的数学模型揭示了最佳的癌症治疗暂停,以克服耐药性. 这种方法导致显著的瘤缩和潜在的治疗结果,指导未来的临床策略.
科学领域:
- 在瘤学瘤学.
- 数学生物学 数学生物学
- 进化生物学 进化生物学
背景情况:
- 耐药性是导致癌症治疗失败和死亡的主要原因.
- 进化原理表明,治疗中断可以延迟或防止耐药性.
- 现有的数学模型对于分析研究来说过于复杂,限制了临床应用.
研究的目的:
- 在遗传和表观遗传抵抗下开发简单,分析可处理的瘤生长数学模型.
- 确定最佳的癌症治疗方案,最大限度地提高瘤缩率.
- 用实验数据验证表观遗传模型,并将其应用于治愈治疗策略.
主要方法:
- 对遗传和表观遗传药物耐药性的两个不同的数学模型的推导.
- 在各种治疗方案下对模型行为进行分析性调查.
- 将表观遗传模型与已发表的异种移植实验数据相匹配.
- 基于合适的模型计算最佳治疗方案.
主要成果:
- 根据耐药性类型 (遗传与表观遗传) 确定了瘤对治疗方案的反应的关键差异.
- 确定最佳治疗策略,最大限度地提高瘤缩率.
- 在表观遗传模型和实验异种移植数据之间表现出了很好的一致性.
- 计算了特定实验的治愈治疗方案,优于专注于瘤稳定的方法.
结论:
- 简单的数学模型是分析复杂的癌症治疗动态的宝贵工具.
- 对这些模型的分析检查可以揭示克服耐药性的最佳策略.
- 衍生的表观遗传模型显示了生物有效性,并可以指导治疗癌症疗法的发展.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


